Colbeck Capital-backed Future Pak withdrew their offer to acquire Vanda Pharmaceuticals for $446m.

Colbeck Capital-backed Future Pak, a contract manufacturer and packager of pharmaceutical and nutraceutical products, withdrew their offer to acquire Vanda Pharmaceuticals, a biopharmaceutical company, for $446m. Future Pak has access to retail, specialty and institutional customers through its expansive partner network. Leveraging its existing infrastructure, Future Pak seeks to make a positive impact on patients by utilizing its reliable supply chain and its quality-first approach.